首页> 外国专利> COMPLEX BIOMARKER GROUP FOR DETECTING LUNG CANCER IN A SUBJECT LUNG CANCER DIAGNOSTIC KIT USING THE SAME METHOD FOR DETECTING LUNG CANCER USING INFORMATION ON COMPLEX BIOMARKER AND COMPUTING SYSTEM EXECUTING THE METHOD

COMPLEX BIOMARKER GROUP FOR DETECTING LUNG CANCER IN A SUBJECT LUNG CANCER DIAGNOSTIC KIT USING THE SAME METHOD FOR DETECTING LUNG CANCER USING INFORMATION ON COMPLEX BIOMARKER AND COMPUTING SYSTEM EXECUTING THE METHOD

机译:使用相同方法通过复杂生物标志物信息检测肺癌的复杂生物标志物组和执行该方法的计算机系统

摘要

The present invention relates to a complex biomarker group for diagnosing lung cancer in a subject, a lung cancer diagnosis kit using the same, a lung cancer diagnosis kit, and a method for using information of a complex biomarker group for diagnosing lung cancer in a subject. According to the present invention, an individual biomarker CEA (Carcinoembryonic antigen), HE4 (human epididymis protein 4), ApoA2 (Apolipoprotein A-II), TTR (Transthyretin) vascular cell adhesion molecule-1) and RANTES (regulated on activation, normal T cell expressed and secreted; There is provided a lung cancer diagnostic kit comprising antibodies specifically binding to a group of biomarkers for lung cancer diagnosis including chemokine (CC motif) ligand 5}, individual biomarkers CEA, HE4, ApoA2, TTR, sVCAM-1 and RANTES . According to the present invention, there is also provided a kit for lung cancer diagnosis, comprising: at least six receiving areas; And at least six biomarker corresponding antibodies each of which is contained in each of the at least six receiving regions and specifically binds to a predetermined individual biomarker, wherein the six or more biomarker corresponding antibodies comprise individual biomarkers CEA, HE4 , ApoA2, TTR, sVCAM-1 and RANTES, respectively. Further, according to the present invention, there is provided a method of detecting a lung cancer, comprising the steps of: (a) providing a computing system with a biomarker expression group of a complex biomarker group for lung cancer, which is measured from a biological sample of a sample group consisting of (1-i) (1-ii) obtaining the expression amount data for each individual biomarker measured from the sample group and the age of the sample group, and preprocessing the expression amount data for each individual biomarker of the sample group (3-i) from the measurement data of the sample population, which is the preprocessed data, or (2-ii) from the measurement data of the sample population and the age of the sample population, Expression data of individual biomarkers of the group of biomarkers for lung cancer diagnosis, measured from the biological sample of the subject, or (3-ii) (B) the computing system preprocesses expression level data for each of the individual biomarkers of the subject, and (4-i) evaluates the expression level of the individual biomarkers of the subject by obtaining the expression level data for each individual biomarker and the age of the subject, (4-ii) determining whether the lung cancer incidence of the subject is determined from the lung cancer determination model using the measurement data and the age of the subject, A method for using information in a complex biomarker group for diagnosis and a computing system for performing the method are also provided.
机译:本发明涉及用于诊断对象的肺癌的复合生物标志物组,使用其的肺癌诊断试剂盒,肺癌诊断试剂盒以及使用用于诊断对象的肺癌的复合生物标志物组信息的方法。 。根据本发明,单独的生物标志物CEA(癌胚抗原),HE4(人附睾蛋白4),ApoA2(载脂蛋白A-II),TTR(运甲状腺素蛋白)血管细胞粘附分子-1)和RANTES(在激活时调节,正常T细胞表达和分泌;提供了一种肺癌诊断试剂盒,该试剂盒包含与一组用于肺癌诊断的生物标记物特异性结合的抗体,包括趋化因子(CC基序)配体5},单个生物标记物CEA,HE4,ApoA2,TTR,sVCAM-1根据本发明,还提供了一种用于肺癌诊断的试剂盒,其包括:至少六个接收区域;以及至少六个生物标志物对应的抗体,所述抗体各自包含在所述至少六个接收区域的每一个中,并且特异性结合预定的单个生物标记,其中六个或多个相应的生物标记抗体分别包含单个生物标记CEA,HE4,ApoA2,TTR,sVCAM-1和RANTES。 y。此外,根据本发明,提供了一种检测肺癌的方法,其包括以下步骤:(a)提供一种计算机系统,该计算机系统具有用于肺癌的复杂生物标志物组的生物标志物表达组,其从由(1-i)(1-ii)组成的样品组的生物样品,获取从样品组和样品组的年龄测得的每个单独的生物标志物的表达量数据,并对每个单独的生物标志物的表达量数据进行预处理(3-i)来自样本人口的测量数据(是预处理数据),或(2-ii)来自样本人口的测量数据和样本人口的年龄,个体的表达数据从受试者的生物样本中测得的用于肺癌诊断的生物标记物组中的生物标记物,或(3-ii)(B)计算系统对t的各个生物标记物的表达水平数据进行预处理(4-i)通过获得每个个体生物标记物的表达水平数据和受试者的年龄来评估个体的生物标志物的表达水平,(4-ii)确定是否该个体的肺癌发生率使用测量数据和受试者的年龄从肺癌确定模型中确定受试者,还提供了使用复杂生物标志物组中的信息进行诊断的方法和执行该方法的计算机系统。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号